ROVI announces the exclusive commercialization of Medikinet y Medicebran in Spain


No votes yet
 
Related
In compliance with the disclosure obligations set forth in Article 227 of Law 6/2023, of 17 March, on Securities Markets and Investment...
2 min
01/04/2026
Total revenue in 2025 was 756.1 million euros, a 1% decrease on 2024. Operating revenue in 2025 was 743.5 million euros, a 3% decrease...
4 min
25/02/2026
In compliance with the disclosure obligations set forth in Article 227 of Law 6/2023, of 17 March, on Securities Markets and Investment...
1 min
18/11/2025